Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
Public ClinicalTrials.gov record NCT01952574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days in participants with episodic migraine.
Study identification
- NCT ID
- NCT01952574
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 483 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 6, 2013 (Actual)
- Primary completion
- Sep 25, 2014 (Actual)
- Completion
- Nov 12, 2019 (Actual)
- Last update posted
- Oct 12, 2022
2013 – 2019
United States locations
- U.S. sites
- 41
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85032 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | National City | California | 91950 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | San Francisco | California | 94109 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Sherman Oaks | California | 91403 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Danbury | Connecticut | 06810 | — |
| Research Site | Fairfield | Connecticut | 06824 | — |
| Research Site | Stamford | Connecticut | 06905 | — |
| Research Site | Bradenton | Florida | 34205 | — |
| Research Site | Melbourne | Florida | 32935 | — |
| Research Site | Palm Beach Gardens | Florida | 33410 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Decatur | Georgia | 30033 | — |
| Research Site | Wichita | Kansas | 67207 | — |
| Research Site | Lexington | Kentucky | 40513 | — |
| Research Site | Louisville | Kentucky | 40213 | — |
| Research Site | Watertown | Massachusetts | 02472 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Ann Arbor | Michigan | 48104 | — |
| Research Site | Kalamazoo | Michigan | 49009 | — |
| Research Site | Southfield | Michigan | 48034 | — |
| Research Site | Plymouth | Minnesota | 55441 | — |
| Research Site | Springfield | Missouri | 65807 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Rochester | New York | 14609 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | Raleigh | North Carolina | 27612 | — |
| Research Site | Philadelphia | Pennsylvania | 19107 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Arlington | Texas | 76017 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Dallas | Texas | 75214 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Salt Lake City | Utah | 84106 | — |
| Research Site | Salt Lake City | Utah | 84124 | — |
| Research Site | Falls Church | Virginia | 22042 | — |
| Research Site | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01952574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2022 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01952574 live on ClinicalTrials.gov.